Abstract:Heart failure and cardiac remodeling following myocardial infarction (MI) depend on capillary density and neovascularization. MicroRNAs (miRNAs), which are small non-coding RNAs that modulate gene expression, play a major role in the pathogenesis of these conditions. Inhibition of these pathways through miRNA sponges, such as antagomiRs or circular decoys (circRNAs), might represent a therapeutic approach for MI. Here, we evaluate the role of miR-146a and present a promising treatment strategy using synthetically designed circular decoys. miRNA-146a expression was analyzed in human vascular cells and mice tissue following either myocardial infarction or hind limb ischemia. CircRNAs were synthetically designed and evaluated. Methods to characterize the effect of inhibition of miR-146a included the quantification of the target gene and protein expression and analysis of cellular functions.miR-146a was significantly upregulated in vitro in senescent cells ( P <0.05) and in vivo in the ischemic myocardium following ligation of the LAD ( P <0.001) in C57BL/6 mice. A circular RNA decoy targeting miR-146a was successfully designed and transfected into vascular cells in vitro . The following analysis showed a significant target upregulation for NOX4, KLF4, and TRAF6 ( P <0.001) after circRNA transfection, also compared to antagomiR transfected cells. Functional analysis revealed improved migration and proliferation capacity in vascular endothelial cells ( P <0.05). First results indicate that inhibition of the upregulation of endothelial miR-146a in mice results in significantly enhanced angiogenesis and revascularization ( P <0.05) accompanied by a significantly reduced myocardial infarct size ( P <0.01) and preserved cardiac function post-MI ( P <0.01). In summary, we could identify miR-146a as a critical regulator of angiogenesis and vascular regeneration, and present a first strategy for angiogenic therapy of ischemic diseases. However, in vitro analysis showed a higher efficiency of circRNAs in the context of inhibiting miR-146a functions in vascular cells. CircRNAs are more stable and more efficient when transfected, compared to antagomiRs, and might be a better alternative and a realistic approach for future clinical studies.

Abstract 103: MiR-4261 Controls Endothelial Cells Angiogenesis

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

miR-376b-5p regulates angiogenesis in cerebral ischemia.

Evaluation Of Mir-29c Inhibits Endotheliocyte Migration And Angiogenesis Of Human Endothelial Cells By Suppressing The Insulin Like Growth Factor 1

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Elevated Expression of Mir302-367 in Endothelial Cells Inhibits Developmental Angiogenesis Via CDC42/CCND1 Mediated Signaling Pathways

MicroRNA-223-3p Inhibits the Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells via Affecting RPS6KB1/hif-1a Signal Pathway

Regulatory Mechanism of Circeif4g2 Targeting Mir-26A in Acute Myocardial Infarction

Abstract P3036: Circular RNA Decoys Targeting MiR-146a As A Promising Therapeutic Strategy To Improve Vascular Regeneration

MicroRNA-126 Regulates Angiogenesis and Neurogenesis in a Mouse Model of Focal Cerebral Ischemia.

Role of Mir-199B-5p in Regulating Angiogenesis in Mouse Myocardial Microvascular Endothelial Cells Through HSF1/VEGF Pathway.

Hypoxia-induced Deregulation of Mir-126 and Its Regulative Effect on VEGF and MMP-9 Expression.

MicroRNA-141 Regulates the Expression Level of ICAM-1 on Endothelium to Decrease Myocardial Ischemia-Reperfusion Injury.

Mir-22-3p Inhibits Arterial Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia by Targeting HMGB1 in Arteriosclerosis Obliterans.

MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF.

MiR-19b-1 Inhibits Angiogenesis by Blocking Cell Cycle Progression of Endothelial Cells

MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells through SNAI2-Mediated GSK-3 β/ β-Catenin Pathway

Mirna-Dependent Cross-Talk Between VEGF and Ang-2 in Hypoxia-Induced Microvascular Dysfunction.

MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells Through SNAI2-Mediated GSK-3β/β-Catenin Pathway

Effect of Mir-144-5p on the Proliferation, Migration, Invasion and Apoptosis of Human Umbilical Vein Endothelial Cells by Targeting RICTOR and Its Related Mechanisms

Abstract 13480: High Density Lipoprotein Promotes Angiogenesis by Suppressing Mir-24-3p Expression